A5037161720- Chronic Obstructive Pulmonary Disease (COPD) Research
- Respiratory Support and Mechanisms
- Asthma and respiratory diseases
- Chronic Disease Management Strategies
- Mobile Health and mHealth Applications
- Inhalation and Respiratory Drug Delivery
- Family and Patient Care in Intensive Care Units
- Health and Wellbeing Research
- Delphi Technique in Research
- Mental Health and Patient Involvement
- Telemedicine and Telehealth Implementation
- Cystic Fibrosis Research Advances
- Older Adults Driving Studies
- Childhood Cancer Survivors' Quality of Life
- School Health and Nursing Education
- Health Literacy and Information Accessibility
- Public Health and Nutrition
- Digital Mental Health Interventions
- Neonatal Respiratory Health Research
- Global Health Workforce Issues
- Agriculture and Farm Safety
COPD Foundation
2019-2025
Manchester University NHS Foundation Trust
2025
European Federation of Allergy and Airways Diseases Patients Associations
2023
Johns Hopkins University
2022
Johns Hopkins Medicine
2022
British Lung Foundation
2021
Clinical trials evaluating the management of acute exacerbations COPD assess heterogeneous outcomes, often omitting those that are clinically relevant or more important to patients. We have developed a core outcome set, consensus-based minimum set outcomes we recommend evaluated in all future clinical on management, improve their quality and comparability. were identified through methodological systematic reviews qualitative interviews with 86 patients from 11 countries globally. The most...
Inhaled corticosteroids (ICS) can improve clinical outcomes in patients with chronic obstructive pulmonary disease (COPD) and eosinophilic airway inflammation, but they also increase the risk of side effects like pneumonia. Blood eosinophils guide ICS use, though evidence is limited. The predictors treatment REsponse to COPD: a randomised controlled trials (RCTs) individual participant Data re-Evaluation (ICS-RECODE) research programme will leverage data from large RCTs identify who benefit...
Although the value of patient and public involvement engagement (PPIE) activities in development new interventions tools is well known, little guidance exists on how to perform these a meaningful way. This particularly true within large research consortia that target multiple objectives, include groups, work across many countries. Without clear guidance, there risk PPIE may not capture opinions needs correctly, thereby reducing usefulness effectiveness tools. Mobilise-D an example consortium...
Background: There is increasing interest in the use of home-based monitoring people with chronic lung diseases to improve access care, support patient self-management, and facilitate collection information for clinical care research. However, integration into research settings requires careful consideration test performance other attributes. no published guidance from professional respiratory societies advance science disease. Methods: An international multidisciplinary panel 32 clinicians,...
Chronic obstructive pulmonary disease (COPD) is a complex lung characterized by airways inflammation and tissue remodeling, leading to loss of small emphysema.1 It the fourth cause death in United States, responsible for more than 150,000 deaths yearly.2 More 15 million people have been diagnosed with COPD and, compared 4.7% large metropolitan areas, staggering 8.2% those living rural areas disease.2 That translates about 3.5 people, it does not include estimated additional 1 undiagnosed.2,...
Background Wellinks is a remote disease management solution that provides novel chronic obstructive pulmonary (COPD) care delivery. Objective This study evaluated the satisfaction, engagement, and clinical outcomes of participants. also investigated cadence health coaching for patients with COPD. Methods A 24-week interventional was conducted by COPD Foundation in 2022. Adults were recruited United States determined to be eligible if they had phone internet access, owned smartphone, not...
This article, co-authored by a patient affected chronic obstructive pulmonary disease (COPD) and respiratory specialist, discusses the patient’s experience of living with and, in particular, impact COPD exacerbations on his life. The physician clinical approach to exacerbations. Together, they provide call action improve management Funding AstraZeneca.
Electronic medication monitors (EMMs) are associated with decreased rescue inhaler use, symptom burden, and increased adherence in asthma. However, the use of EMMs people chronic obstructive pulmonary disease (COPD) using ELLIPTA dry powder has not been studied.This was an open-label, single-arm, prospective observational study application (app) over 12 weeks up to 24 (April-October 2019) self-reported COPD aged ≥40 years enrolled Patient-Powered Research Network, inhaler. The primary...
Rationale: Self-management support (SMS) is an essential component of care for patients who have chronic obstructive pulmonary disease (COPD), but there little evidence on how to provide SMS most effectively these patients. Peer (i.e., provided by a person with similar medical condition) has been successfully used promote self-management among various conditions, yet no randomized studies focused testing its effects COPD. Objectives: To assess whether adding peer healthcare professional...
<sec> <title>BACKGROUND</title> Wellinks is a remote disease management solution that provides novel chronic obstructive pulmonary (COPD) care delivery. </sec> <title>OBJECTIVE</title> This study evaluated the satisfaction, engagement, and clinical outcomes of participants. also investigated cadence health coaching for patients with COPD. <title>METHODS</title> A 24-week interventional was conducted by COPD Foundation in 2022. Adults were recruited United States determined to be eligible if...
<sec> <title>UNSTRUCTURED</title> Although the value of patient and public involvement engagement (PPIE) activities in development new interventions tools is well known, little guidance exists on how to perform these a meaningful way. This particularly true within large research consortia that target multiple objectives, include groups, work across many countries. Without clear guidance, there risk PPIE may not capture opinions needs correctly, thereby reducing usefulness effectiveness...